Welcome to our dedicated page for Columbia Financial, Inc./MD/ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Columbia Financial, Inc./MD/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Columbia Financial, Inc./MD/'s regulatory disclosures and financial reporting.
Columbia Financial, Inc. director Noel R. Holland reported an acquisition of 15.7214 shares of Common Stock equivalents on August 7, 2026, as a grant/award under a stock-based deferral plan at $10.84 per share. The footnotes explain this represents phantom stock purchased on a non-discretionary basis by the trustee of a rabbi trust under the Columbia Bank Stock Based Deferral Plan, to be settled in shares upon distribution. Following this award, indirect holdings in the deferral plan total 29,690.2255 stock units. Holland also reports 80,797 directly held Common Shares, 109,316 Common Shares held indirectly via a SEP-IRA, and 6,494 Common Shares held indirectly as Stock Awards that vest on March 12, 2027. In addition, fully vested stock options remain outstanding, covering 183,246 shares of Common Stock at an exercise price of $7.10 per share, expiring July 23, 2029.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported an acquisition of 63.1568 shares of Columbia Financial common stock on August 7, 2026 at $10.84 per share. The shares represent phantom stock purchased on a non-discretionary basis in a rabbi trust under a stock-based deferral plan and will be settled in shares upon distribution.
Following this transaction, Klimowich holds 20,464.6506 indirect stock-based deferral units, along with various direct and indirect common stock holdings and multiple stock option awards with exercise prices between $7.10 and $8.31 per share.
Columbia Financial, Inc. President & CEO Thomas J. Kemly reported an award of 171.3736 units of Common Stock on August 7, 2026, at $10.84 per unit, credited as phantom stock under the Columbia Bank Stock Based Deferral Plan. This indirect position, held through a rabbi trust, increased his stock-based deferral plan balance to 153,658.8392 units. He also reports direct ownership of 588,391 shares of Common Stock and multiple indirect holdings through a 401(k), SERP, ESOP, spouse, and performance-based stock award vehicles, plus several option grants over Columbia Financial’s stock with exercise prices between $7.10 and $8.31 and expirations from 2029 to 2036.
Columbia Financial, Inc. reported solid mid‑year results while preparing for a major capital and M&A step. As of June 30, 2026, total assets were about $12.17B, up from $11.02B at year‑end 2025, driven mainly by loan growth and a large increase in cash and cash equivalents to about $1.09B. Net loans rose to roughly $8.42B, and deposits increased to about $9.50B, strengthening the funding base.
For the quarter, net interest income improved to $62.9M from $53.7M a year earlier as interest expense declined, supporting quarterly net income of $14.5M versus $12.3M. For the first six months, net income reached $27.6M compared with $21.2M, with diluted EPS rising to $0.27 from $0.21. The allowance for credit losses on loans increased to $71.1M, and non‑accrual loans were $43.0M, reflecting continued credit risk management.
The company also completed, on July 20, 2026, a $1.7B second‑step conversion offering and the $580.3M acquisition of Northfield Bancorp, Inc., largely paid in stock. These transformative transactions, and the resulting 269.5M common shares outstanding, will affect periods after June 30 and are not yet reflected in the reported operating results.
Columbia Financial, Inc. reported stronger results for the quarter ended June 30, 2026, with net income of $14.5 million and earnings of $0.14 per share, up from $12.3 million and $0.12 a year earlier. Core net income was $15.1 million, or $0.15 per share. For the first six months of 2026, net income rose to $27.6 million, or $0.27 per share, compared with $21.2 million, or $0.21 per share.
Performance benefited from a 17.2% increase in quarterly net interest income to $62.9 million and net interest margin expansion to 2.44% from 2.19%, driven mainly by lower funding costs. Total assets grew 10.5% since year-end to $12.2 billion, supported by commercial loan growth and significant cash from depositor stock subscriptions.
The company completed its second-step conversion offering in July 2026, raising gross proceeds of $1.7 billion, and closed the acquisition of Northfield Bancorp, Inc., adding approximately $5.8 billion of assets on a pro forma basis and expanding its New Jersey and New York metro presence. The board approved a quarterly cash dividend of $0.05 per share payable August 26, 2026. Credit metrics remained controlled, with allowance for credit losses at 0.84% of total gross loans and non-performing loans at 0.51% of total gross loans, though non-performing balances and provisions increased.
Columbia Financial, Inc./MD/ director Jim Hobart Wainwright purchased 10,000 shares of common stock on July 20, 2026 at $10.00 per share in an open market or private transaction. Following this purchase, he directly holds 17,055 common shares.
In addition, he reports indirect holdings of 4,389 shares through an ESOP and 6,494 shares from stock awards granted under the Columbia Financial, Inc. 2019 Equity Incentive Plan, which vest in one year on March 12, 2027.
Columbia Financial, Inc./MD/ director Michael Massood Jr. reported purchasing 25,000 shares of Common Stock of CLBK on July 20, 2026 at $10.00 per share, in open-market or private transactions executed under a Rule 10b5-1 trading plan. The purchases were made indirectly through an IRA (10,000 shares, bringing that account to 57,044 shares) and a Roth IRA (15,000 shares, bringing that account to 93,063 shares). He also reports direct ownership of 94,613 Common shares, 6,494 indirectly held shares from Stock Awards under the 2019 Equity Incentive Plan that vest on March 12, 2027, and fully vested stock options on 183,246 shares at an exercise price of $7.10 expiring July 23, 2029.
Columbia Financial, Inc. executive Lewis Oliver Edward Jr, SEVP & Head Commercial Banking, reported open-market purchases of 15,000 shares of common stock on 2026-07-20 at $10.00 per share, split between 500 directly held shares and 14,500 acquired through a 401(k). After these trades, he reports 65,296 directly held shares plus additional indirect holdings in benefit and award plans, and maintains several option grants under the 2019 Equity Incentive Plan with exercise prices between $7.25 and $8.31. The Rule 10b5-1 checkbox is not marked, indicating these purchases were not made pursuant to an affirmed trading plan.
Columbia Financial, Inc. director Elizabeth E. Randall reported buying a total of 49,980 shares of common stock on July 20, 2026 at $10.00 per share across direct, Roth IRA, and stock-based deferral plan accounts. Following these transactions, she held 105,490 direct shares, plus indirect common stock holdings and fully vested stock options for 137,442 shares at a $7.10 exercise price expiring July 23, 2029.
Lucy Sorrentini, a director of Columbia Financial, Inc., purchased 20,000 shares of Common Stock on July 20, 2026 at $10.00 per share, held indirectly through an IRA, bringing that IRA position to 20,000 shares. She also reports 32,716 shares held directly, 16,896 shares held through a Stock-Based Deferral Plan, and 6,494 shares held via Stock Awards granted under the 2019 Equity Incentive Plan that vest in one year on March 12, 2027. The Rule 10b5-1 checkbox is not marked as a trading plan.